Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04938024 · ClinicalTrials.gov registry record · NA

Hmong Microbiome ANd Gout, Obesity, Vitamin C (HMANGO-C)

A NA study, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
135
Enrollment target

NCT04938024 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 135 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04938024, a NA study, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
135 participants
Enrollment target

Study Summary

Investigators seek to quantify the impact of vitamin C on patient outcomes, including serum urate level, gout-related symptoms, and obesity (measured by BMI) in both healthy Hmong adults and in Hmong patients with hyperuricemia (HU) and/or gout; identify associations between individuals' taxonomic and functional patterns of gut microbiota and its impact on the serum urate-lowering effect of vitamin C; compare taxonomic and functional patterns of gut microbiota between people with HU and/or gout and people without HU and gout; and identify associations between individuals' taxonomic and functional patterns of gut microbiota and self-reported acute gout trigger foods.

Interventions

  • DIETARY_SUPPLEMENT Vitamin C

Trial Details

FieldValue
Enrollment Target 135 participants
Start Date 2021-03-28
Est. Completion 2023-08-30
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT04938024

The ClinicalTrials.gov registry entry for NCT04938024 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Vitamin C is the first listed.

NCT04938024 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04938024 about?

NCT04938024 is a clinical study titled "Hmong Microbiome ANd Gout, Obesity, Vitamin C (HMANGO-C)". Investigators seek to quantify the impact of vitamin C on patient outcomes, including serum urate level, gout-related symptoms, and obesity (measured by BMI) in both healthy Hmong adults and in Hmong patients with hyperuricemia (HU) and/or gout; identify associations between individuals' taxonomic a...

What is the current status of trial NCT04938024?

This trial is currently completed. It is a NA study. The enrollment target is 135 participants. The study started on 2021-03-28. Estimated completion is 2023-08-30.

What interventions are being tested in trial NCT04938024?

The interventions under investigation include: Vitamin C (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04938024?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.